Guest guest Posted November 11, 2001 Report Posted November 11, 2001 - Steven.Powers.MD Sunday, October 28, 2001 2:46 AM Common virus linked to male infertility /Germline gene therapy boosted by modified sperm Don't expect the drinking water helps with all the estrogen in. N Common virus linked to male infertility http://www.newscientist.com/news/news.jsp?id=ns99991483 13:20 26 October 01 Emma Young A common virus may be linked to infertility in men, say German scientists. They analysed semen samples from almost 100 men and found that 38 per cent of abnormal samples were infected with adeno-associated virus (AAV), compared with only 4.6 per cent of normal samples. AAV infects 40 per cent of people by the age of 20 and most people are infected by middle age. " The virus was not thought to be pathogenic, " says Jörg Schlehofer of the German Cancer Research Centre in Heidelberg, who led the new research. " But our research raises the issue of whether sperm cells used in ICSI or other reproductive techniques should be checked for AAV prior to fertilisation. " ICSI involves injecting a single sperm directly into an egg. Christopher Barratt, an expert on sperm biology at Birmingham University, says: " The idea that infection with certain viruses - such as HIV - can cause sperm abnormalities is not new. But AAV is not generally thought to be pathogenic and that's what makes this finding interesting. " AAV is used in gene therapy, to shuttle new DNA into a cell. It has recently been used to introduce DNA into mice sperm stem cells. " The virus is a very good vector system. But nobody has really looked at what tissues it targets in humans, " says Schlehofer. More work is needed to investigate whether AAV infection really does cause infertility, he says. Strong bond Schlehofer's team analysed semen samples from 73 men who were participating in a fertility programme and 22 men with no history of infertility. They used standard DNA analysis techniques to look for traces of the virus. Earlier work by the team on a small number of infertile men had found evidence of a high AAV infection rate. This work also showed that the viral DNA bound strongly with the sperm, but not with other constituents of semen. " But these were very few men, and we did not look at normal samples, " says Schlehofer. In the new study, they found that men with either very low sperm concentrations or defects in sperm motility were most likely to be infected with AAV. There is some evidence that the virus can interfere with cell differentiation. " It could be that important cells associated with the production of sperm and sperm maturation could be affected, and this results in the malformations, " says Schlehofer. Early miscarriage AAV infection has previously been linked to very early miscarriage. " It is possible that if an embryo is infected through an infected sperm, for example, the very sophisticated immunotolerance between the embryo and the mother is affected, and this could trigger miscarriage. But this is speculation - much more work needs to be done to investigate, " says Schlehofer. There is no " cure " for AAV, since it was not thought to be harmful to health, he adds. " But with ICSI, for example, there is not a very high baby take-home rate. Maybe this is due to infected sperm. If we could screen samples or get rid of the virus in assisted reproduction techniques, perhaps we could improve this rate, " Schlehofer says. It is not clear how AAV infection of the testis could occur, the team says. But it appears that the virus does " target " genital tissue in particular. Journal reference: Human Reproduction (vol 16, p 2333) Germline gene therapy boosted by modified sperm http://www.newscientist.com/news/news.jsp?id=ns99991462 13:18 23 October 01 Emma Young Using genetically modified sperm to prevent disease in future generations has come a step closer, say US scientists. They have succeeded in using a virus to introduce a foreign gene into up to 20 per cent of mouse sperm stem cells. This gene was then passed on for at least three generations. Gene therapy to treat genetic disease in adults has shown some success. But previous attempts to modify sperm for 'germline' therapy - in which modifications are passed to offspring - have not produced good results, say Ralph Brinster of the University of Pennsylvania and his colleagues. Culturing samples of stem cells for a shorter period of time allowed them to introduce a marker gene into 20 per cent of mouse sperm stem cells. This represents a ten-fold increase in success rate over past attempts. These cells were then transplanted into recipient mice. The inserted foreign genes appeared in about 4.5 per cent of the offspring of these mice Self-renewing " Spermatatogonial " stem cells, which are found in the testes throughout life, are the only cells in the male that self-renew after birth and contribute genes to subsequent generations. " These cells are thought by some to provide the best approach, should human germline therapy be undertaken in the future, " Brinster says. The number of stem cells in cultured testis samples is known to decrease by about half after three days and by 90 per cent after seven days, the team say. They suggest that a shorter culture time could be a key reason for their improved results. The idea of germline engineering in humans is controversial. Some argue it could lead to unforeseen side effects being passed down generations of people. The technique is more likely to be applied to livestock in the short term. It could enable the production of herds or flocks of animals modified to be more disease-resistant, to produce useful proteins in their milk or to act as better models for human diseases. Journal reference: Proceedings of the National Academy of Sciences (vol 2, no 43) Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.